CAS: 50824-04-9; 4-Bromo-2-(Trifluoromethyl)Phenol

该化合物是一种有机化合物,其特征是存在溴原子和附属于一种酚状结构的三氟甲基组;其分子式为C7H4BRF3O,表明存在7个碳原子,4个氢原子,1个溴原子,3个氟原子和1个氧原子;该化合物一般在室温上呈现为固体,并因其由三氟甲基组所赋予的独特电子特性而有可能在制药和农用化学中应用.溴和三氟甲基分组加强了其再活性,并影响其溶解于各种溶剂中.此外,4-Bromo-2-(三氟甲基)苯醇可能展示生物活动,使其对药用化学感兴趣.在处理预防措施时,应参考安全数据表,因为卤化合物可能对环境和健康造成风险.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

2-(trifluoromethyl)phenol 4-bromo-1-methoxy-2-(trifluoromethyl)benzene 4-bromo-phenol Langlois reagent 5-bromo-2-hydroxy-3-(trifluoromethyl)benzaldehyde 4-bromo-1-phenylmethoxy-2-(trifluoromethyl)benzene 4-(3-hydroxypropyl)-2-(trifluoromethyl)phenol 4-(benzyloxy)-3-(trifluoromethyl)benzaldehyde

合成工艺路线路线简述

    4-溴-2-(三氟甲基)苯甲醚置于碳酸氢钠体系中,用 氢溴酸,溶剂黄146 作为反应溶剂,化学反应生成 4-溴-2-三氟甲基苯酚
    参考文献:Alkyne Compounds With Mch Antagonistic Activity And Medicaments Comprising These Compounds
    标题:Alkyne Compounds With Mch Antagonistic Activity And Medicaments Comprising These Compounds
    摘要:本发明涉及一般式i的炔烃化合物 1 其中基团和残基a,B,W,X,Y,Z,R 1 和r 2 具有权利要求中给出的含义.本发明还涉及含有根据本发明至少一种炔烃的药物组合物.鉴于它们的mch受体拮抗活性,根据本发明的药物组合物适用于治疗代谢紊乱和/或进食紊乱,特别是肥胖症,暴食症,厌食症,过度进食和糖尿病.

    海关参考信息

    专利信息


    专利号:US-9994558-B2
    优先权日:2013-09-20
    标题 :Multicyclic compounds and methods of using same
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

    专利号:US-9938258-B2
    优先权日:2012-11-29
    标 题:Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
    发明人:BALOGLU ERKAN; SHECHTER SHARON; SHACHAM SHARON; MCCAULEY DILARA; SENAPEDIS WILLIAM; GOLAN GALI; KALID ORI
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to substituted 2,3-dihydrobenzofuranyl compounds, and more particularly to a compound represented by Structural Formula I: n nor a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.

    专利号:US-9856241-B2
    优先权日:2013-07-03
    标 题:Substituted benzofuranyl and benzoxazolyl compounds and uses thereof
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to substituted benzofuranyl and substituted benzoxazolyl compounds, and more particularly to a compound represented by Structural Formula (A): or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula (A), or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.
    天津津御达化工科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinyudachem.com
    企业联系电话:022-23854368👤
    📞天津津御达化工科技有限公司 ⚠️参考联系方式
    联系人:王经理
    电话:022-23854368
    手机:13011382049
    传真:022-23854368
    邮箱:sales@jinyudachem.com
    通信地址: 天津市华苑产业区华天道8号海泰信息广场C座209室
    邮编: 300400
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市华苑产业区华天道8号海泰信息广场C座209室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知